+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

From
From
From
From
From
From
Bone Marrow Transplant Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Bone Marrow Transplant Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
Rabies Infection Pipeline Analysis Report 2025 - Product Thumbnail Image

Rabies Infection Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Bacterial Pneumonia Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Bacterial Pneumonia Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Rabies Infection Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Rabies Infection Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
From
Topical Skin Infection Treatment Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Topical Skin Infection Treatment Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more